ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.903,39
1,31%
S&P 500
5.996,66
1,00%
Dow Jones
43.487,83
0,78%
Euro vs US Dollar
1,03035
0,00%
Bitcoin
103.094,35
-0,99%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC

  6. Algernon Pharmaceuticals Inc (QB) (AGNPF) Börsenkurse

Algernon Pharmaceuticals Inc (QB)

Algernon Pharmaceuticals Inc (QB) (AGNPF)

USOTC
0,05
0,00
(0,00%)
Geschlossen 18 Januar 10:00PM
Verzögert um 15 Minuten

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,05
Gebot
0,0051
Fragen
0,2345
Volumen
-
0,00 Tagesbereich 0,00
0,0375 52-Wochen-Bereich 0,123
Marktkapitalisierung
1,365M
Handelsende
0,05
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
7.059
Ausgegebene Aktien
27.300.779
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,72
Gewinn pro Aktie (EPS)
-0,02
Erlöse
-
Nettogewinn
-503k

Über Algernon Pharmaceuticals Inc (QB)

Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically inv... Algernon Pharmaceuticals is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off label prescription writing. Mehr anzeigen

Sektor
Surgical,med Instr,apparatus
Branche
Surgical,med Instr,apparatus
Website
www.algernonpharmaceuticals.com
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
Algernon Pharmaceuticals Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker AGNPF. The last closing price for Algernon Pharmaceuticals (QB) was US$0,05. Over the last year, Algernon Pharmaceuticals (QB) shares have traded in a share price range of US$ 0,0375 to US$ 0,123.

Algernon Pharmaceuticals (QB) currently has 27.300.779 shares in issue. The market capitalisation of Algernon Pharmaceuticals (QB) is US$1,37 million. Algernon Pharmaceuticals (QB) has a price to earnings ratio (PE ratio) of -2.72.

AGNPF Neueste Nachrichten

Weitere Nachrichten

Algernon Pharmaceuticals Considers Adding Lung Scarring as an Additional Endpoint for its Phase 2b/3 COVID-19 Study Protocol

VANCOUVER, British Columbia, Feb. 10, 2021 -- InvestorsHub NewsWire -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the "Company" or...

11 Februar 2021
InvestorsHub NewsWire

Algernon Receives U.S. FDA Clearance for Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19

Algernon Receives U.S. FDA Clearance for Multinational Phase 2b/3 Human Study to Evaluate Ifenprodil as a Potential Therapeutic for COVID-19 VANCOUVER, British Columbia, June 04, 2020...

04 Juni 2020
InvestorsHub NewsWire

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard

Algernon Receives Positive Feedback from U.S. FDA for Ifenprodil COVID-19 Human Trial; Appoints U.S. Ambassador (Rtd) Howard Gutman to Advisory Board VANCOUVER, British Columbia, Canada...

13 April 2020
InvestorsHub NewsWire

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency

Algernon Announces Filing of U.S. FDA Pre-IND Meeting Request for Ifenprodil Coronavirus Trial, Expanded Access, and Emergency Use VANCOUVER, British Columbia, Canada -- March 13, 2020...

13 März 2020
InvestorsHub NewsWire

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus

Algernon Explores the Use of NP-120 (Ifenprodil) as a Novel Treatment for Coronavirus VANCOUVER, British Columbia, Canada -- March 6, 2020 -- InvestorsHub NewsWire -- Algernon...

06 März 2020
InvestorsHub NewsWire
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.00908-15.36899119840.059080.06250.05117860.05733431CS
40.009322.85012285010.04070.06250.0375104370.05271863CS
12-0.0063-11.1900532860.05630.070.037570590.05387949CS
26-0.04975-49.87468671680.099750.1050.037573520.06705476CS
52-0.01092-17.92514773470.060920.1230.0375104190.07450488CS
156-1.9543725-97.50545370182.00437252.3198750.035391990.23587895CS
2600.034975232.7787021630.0150252.3198750.00852701750.05770576CS

AGNPF - Frequently Asked Questions (FAQ)

What is the current Algernon Pharmaceuticals (QB) share price?
The current share price of Algernon Pharmaceuticals (QB) is US$ 0,05
How many Algernon Pharmaceuticals (QB) shares are in issue?
Algernon Pharmaceuticals (QB) has 27.300.779 shares in issue
What is the market cap of Algernon Pharmaceuticals (QB)?
The market capitalisation of Algernon Pharmaceuticals (QB) is USD 1,37M
What is the 1 year trading range for Algernon Pharmaceuticals (QB) share price?
Algernon Pharmaceuticals (QB) has traded in the range of US$ 0,0375 to US$ 0,123 during the past year
What is the PE ratio of Algernon Pharmaceuticals (QB)?
The price to earnings ratio of Algernon Pharmaceuticals (QB) is -2,72
What is the reporting currency for Algernon Pharmaceuticals (QB)?
Algernon Pharmaceuticals (QB) reports financial results in CAD
What is the latest annual profit for Algernon Pharmaceuticals (QB)?
The latest annual profit of Algernon Pharmaceuticals (QB) is CAD -503k
What is the registered address of Algernon Pharmaceuticals (QB)?
The registered address for Algernon Pharmaceuticals (QB) is SUITE 1500 - 1055 WEST GEORGIA STREET, VANCOUVER, BRITISH COLUMBIA, V6E 4N7
What is the Algernon Pharmaceuticals (QB) website address?
The website address for Algernon Pharmaceuticals (QB) is www.algernonpharmaceuticals.com
Which industry sector does Algernon Pharmaceuticals (QB) operate in?
Algernon Pharmaceuticals (QB) operates in the SURGICAL,MED INSTR,APPARATUS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TMGIMarquie Group Inc (PK)
US$ 0,0002
(19.900,00%)
4,03M
SEANSAEAN Group Inc (PK)
US$ 1,87
(18.600,00%)
100
ZPASZoompass Holdings Inc (CE)
US$ 0,0001
(9.900,00%)
675
GMPRGourmet Provisions International Corporation (PK)
US$ 0,0001
(9.900,00%)
35,31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(9.900,00%)
18,06M
STNXStartronix International Inc (CE)
US$ 0,000001
(-99,99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0,000001
(-99,97%)
2,03k
ISOLImage Software Inc (CE)
US$ 0,000001
(-99,91%)
59,2k
NBIONascent Biotech Inc (CE)
US$ 0,0002
(-99,55%)
8,7k
FHBCFernhill Beverage Inc (CE)
US$ 0,000001
(-99,24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
349,77M
VTXBVortex Brands Company (PK)
US$ 0,0002
(0,00%)
297,52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0,0002
(0,00%)
233,53M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
184,12M
HMBLHUMBL Inc (PK)
US$ 0,0009
(-5,26%)
179,2M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

USOTC
AGNPF
Algernon Pharmaceuticals (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten